Pharmacetical Newswire

Pharmaceutical News!

Press release distribution service
Pharmaceutical Links

Pharmanewswire.Com: Pharmaceutical News

Global Autoimmune Disease Diagnostics Market-Segmented by Disease Type, Diagnosis, and Geography-Growth, Trends, and Forecast (2018-2023)

 



(PharmaNewsWire.Com, June 14, 2018 ) Global Autoimmune Disease Diagnostics Market 2018-2023:
The global autoimmune disease diagnostics market is expected to register a CAGR of 7.5% during the forecast period of 2018–2023.The key factors propelling the market include the growing public awareness of autoimmune disease, improving laboratory automation, partnerships with physicians and clinical laboratories, technological advancements, expansion in coverage allowed by the Patient Protection and Affordable Care Act.

Major Players: F. HOFFMANN-LA ROCHE, EUROIMMUN AG, INOVA DIAGNOSTICS, INC., SIEMENS HEALTHINEERS, INC., BIOMÉRIEUX, TRINITY BIOTECH, THERMO FISHER SCIENTIFIC, MYRIAD GENETICS, ABBOTT LABORATORIES, and BIO-RAD LABORATORIES, among others.

Get Sample Copy of Global Autoimmune Disease Diagnostics Market @ http://orbisresearch.com/contacts/request-sample/2131406

Companies Mentioned:
F. Hoffmann-la Roche, Euroimmun AG, Inova Diagnostics, Inc., Siemens Healthineers, Inc., Biomérieux, Trinity Biotech, Thermo Fisher Scientific, Myriad Genetics, Abbott Laboratories, Bio-rad Laboratories

Growing Public Awareness of Autoimmune Disease
The rising awareness of autoimmune diseases through programs of research, education, support, and advocacy is a key factor boosting the usage rates. It is imperative that the public is more aware of their own risk factors for developing autoimmune diseases so that, as symptoms occur, they can seek diagnosis and begin a treatment regimen. The United States has the highest incidence of autoimmune diseases with about 50 million patients. The American Autoimmune Related Diseases Association (AARDA) is dedicated to eradicate autoimmune diseases. The AARDA aims to increase awareness about the socioeconomic impact of autoimmunity through fostering and facilitating collaboration in the areas of education, public awareness, research, and patient services in an effective, ethical, and efficient manner. Similarly, there are other organizations who are striving to improve the R&D funding, patient awareness, and provide other socio-economic benefits to the patients. The increase in awareness levels coupled with improving healthcare infrastructure and reimbursement coverage is expected to drive the market expansion over the forecast period. The other factors, such as improved laboratory automation, partnerships with physicians and clinical laboratories, technological advancements, and expansion in coverage allowed by the Patient Protection and Affordable Care Act are driving the autoimmune disease diagnostics market.

Slow Turnaround Time for Autoimmune Disease Diagnostic Test Results
Diagnosis of autoimmune diseases is a time-consuming process. It involves procedures such as serum testing for diseases like rheumatoid arthritis, Addison’s disease, Hashimoto’s disease, and others. Testing protocols allow autoimmune disorders to be diagnosed in a highly efficient and cost-effective manner. However, the turnaround time for the test results is slow, owing to lesser automation techniques. It takes days to deliver all test results to the patients with the proper explanation of false positive results. For example, autoimmune lymph proliferative syndrome is an autoimmune disease with a turnaround time of up to 12 weeks. A single gene sequencing takes four weeks. Therefore, this slow turnaround time is hindering the global autoimmune disease diagnostics market. The other factor, such as high frequency of false positive result is also hindering the market.

United States to Lead the Market in North America
In 2017, the United States autoimmune disease diagnostics market held the largest market share in North America due to the increasing healthcare expenditure and increasing prevalence of autoimmune diseases in the region. In the United States, 16% of the population suffers from autoimmune diseases, 78% of whom are women.

Enquire Before Buying Global Autoimmune Disease Diagnostics Market Report @ http://orbisresearch.com/contacts/enquiry-before-buying/2131406

Key Developments in the Market
October 2017: The US Food and Drug Administration cleared Roche's Cobas Cdiff Nucleic acid test.
August 2017: BioMérieux, received SERVICE 800 award in an annual conference held in Minneapolis.
August 2017: Thermo Fisher Scientific acquired Patheon.

Reasons to Purchase the Report
Follow the current and future autoimmune disease diagnostics market in the developed and emerging markets.
Examining the various perspectives of the market with the help of Porter’s Five Forces Analysis.
Identify the segment that is expected to dominate the market.
Identify the regions that are expected to witness the fastest growth during the forecast period.
Identify the latest developments, market shares, and strategies employed by the major market players.
3-month analyst support along with the Market Estimate sheet (in Excel).

Customization of the Report
This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.

Table Of Content:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
Continued…

Place Purchase Order for Global Autoimmune Disease Diagnostics Market Report @ http://orbisresearch.com/contact/purchase/2131406

Orbis Research

Hector Costello

+1 (214) 884-6817

sales@orbisresearch.com

Source: EmailWire.Com

Source: EmailWire.com


Pharmaceutical Sponsors

Free Biotech & Pharmaceutical Magazines

Pharmacy Newswire Video Feed

Pharmaceutical & Biotech Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:

IronPort Provides Email Management and Analysis for a Premier Health Care Solutions Provider
Pharmaceutical & Medical Packaging News
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com, or contact us.
Copyright 2009 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
Pharmanewswire.com - Pharmaceutical Newswire and Press Release service of GroupWeb Media LLC